Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunoinformatics in personalized medicine.

Kamalakar Gulukota1

  • 1grk bioSciences Private Limited, #210, My Home Tycoon, 6-3-1192, Begumpet, Hyderabad 500 016, India.

Novartis Foundation Symposium
|January 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SILO: A Computational Method for Detecting Copy Number Gain in Clinical Specimens Analyzed on a Next-Generation Sequencing Platform.

The Journal of molecular diagnostics : JMD·2021
Same author

Flype: Software for enabling personalized medicine.

American journal of medical genetics. Part C, Seminars in medical genetics·2020
Same author

LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor β Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.

Human gene therapy·2020
Same author

An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.

Human gene therapy·2019
Same author

Bayesian inference for intratumour heterogeneity in mutations and copy number variation.

Journal of the Royal Statistical Society. Series C, Applied statistics·2017
Same author

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

European urology·2016

Immunological tests are crucial for personalized medicine, enabling tailored treatments by classifying individuals. This approach, using methods like MHC allele frequency analysis, predicts patient responses for better healthcare outcomes.

Area of Science:

  • Immunology
  • Genomics
  • Personalized Medicine

Background:

  • Disease classification has evolved from broad categories to finer distinctions based on therapy response, genetics, histology, and transcriptional profiling.
  • The next frontier in disease categorization is patient typing, focusing on individual characteristics (disease X in person of type Y) for personalized medicine.
  • Immunology has historically contributed to personalized medicine through tests like blood grouping and penicillin allergy testing.

Purpose of the Study:

  • To argue for the significant role of immunological tests in the future of personalized medicine.
  • To present methods for personalizing vaccines using human population MHC allele frequencies.
  • To describe techniques for predicting peptide binding to class I MHC molecules.

Main Methods:

Related Experiment Videos

  • Analysis of Major Histocompatibility Complex (MHC) allele frequencies in diverse human populations.
  • Development of predictive models for peptide binding to class I MHC molecules.
  • Application of immunoinformatics tools for personalized vaccine design.

Main Results:

  • Demonstrated feasibility of personalizing vaccines based on population-specific MHC profiles.
  • Established methods for predicting peptide-MHC interactions, crucial for immune response prediction.
  • Highlighted the potential of immunoinformatics in advancing personalized medicine.

Conclusions:

  • Immunological tests are essential for the advancement of personalized medicine.
  • Immunoinformatics, coupled with immunological testing, will be pivotal in realizing personalized medicine.
  • Future research should focus on integrating immunological data for tailored therapeutic strategies.